$43.87
2.12% yesterday
NYSE, Aug 12, 10:00 pm CET

CryoLife Stock price

$43.85
+12.17 38.42% 1M
+14.00 46.90% 6M
+15.26 53.38% YTD
+18.72 74.49% 1Y
+21.13 93.00% 3Y
+22.99 110.21% 5Y
+33.37 318.42% 10Y
+37.20 559.40% 20Y
NYSE, Closing price Tue, Aug 12 2025
+0.89 2.07%

Key metrics

Basic
Market capitalization
$1.8b
Enterprise Value
$2.1b
Net debt
$280.7m
Cash
$37.7m
Shares outstanding
42.7m
Valuation (TTM | estimate)
P/E
negative | 382.9
P/S
4.7 | 4.2
EV/Sales
5.4 | 4.9
EV/FCF
negative
P/B
6.2
Dividends
DPS
$0.00
Yield 1Y | 5Y
0.0% | 0.0%
Growth 1Y | 5Y
- | -
Payout 1Y | 3Y
0.0% | 0.0%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$390.1m | $435.9m
EBITDA
$37.0m | $88.3m
EBIT
$21.1m | $29.9m
Net Income
$-21.4m | $4.8m
Free Cash Flow
$-440.0k
Growth (TTM | estimate)
Revenue
5.9% | 12.2%
EBITDA
-5.2% | 59.4%
EBIT
-9.3% | -23.1%
Net Income
-123.0% | 135.9%
Free Cash Flow
-104.1%
Margin (TTM | estimate)
Gross
63.9%
EBITDA
9.5% | 20.2%
EBIT
5.4%
Net
-5.5% | 1.1%
Free Cash Flow
-0.1%
Financial Health
Equity Ratio
35.0%
Return on Equity
-4.8%
ROCE
2.9%
ROIC
2.7%
Debt/Equity
1.1
More
EPS
$-0.5
FCF per Share
$0.0
Short interest
3.6%
Employees
2k
Rev per Employee
$240.0k
Show more

Is CryoLife a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

CryoLife Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a CryoLife forecast:

12x Buy
92%
1x Hold
8%

Analyst Opinions

13 Analysts have issued a CryoLife forecast:

Buy
92%
Hold
8%

Financial data from CryoLife

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
390 390
6% 6%
100%
- Direct Costs 141 141
8% 8%
36%
249 249
5% 5%
64%
- Selling and Administrative Expenses 187 187
9% 9%
48%
- Research and Development Expense 28 28
1% 1%
7%
37 37
5% 5%
9%
- Depreciation and Amortization 16 16
1% 1%
4%
EBIT (Operating Income) EBIT 21 21
9% 9%
5%
Net Profit -21 -21
123% 123%
-5%

In millions USD.

Don't miss a Thing! We will send you all news about CryoLife directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

CryoLife Stock News

Neutral
Seeking Alpha
4 days ago
Artivion, Inc. (NYSE:AORT ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Lance A. Berry - Executive VP of Finance & CFO Pat MacKin - Corporate Participant Conference Call Participants Daniel Walker Stauder - Citizens JMP Securities, LLC, Research Division Destiny Alexandra Hance Buch - Ladenburg Thalmann & Co. Inc., Research Division John Glenn McAulay - Stife...
Positive
The Motley Fool
5 days ago
Artivion (AORT) Q2 EPS Jumps 243%
Neutral
PRNewsWire
5 days ago
Second Quarter Highlights: Achieved revenue of $113.0 million in the second quarter of 2025 versus $98.0 million in the second quarter of 2024, an increase of 15% on a GAAP basis and 14% on a non-GAAP constant currency basis Net income was $1.3 million, or $0.03 per fully diluted share and non-GAAP net income was $10.7 million, or $0.24 per fully diluted share in the second quarter of 2025 Adju...
More CryoLife News

Company Profile

CryoLife, Inc. engages in the manufacture, process and distribution of medical devices. It operates through the following segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of BioGlue; JOTEC products, On-X products, CardioGenesis cardiac laser therapy, PerClot and PhotoFix. The Preservation Services segment focuses on external services revenues from the preservation of cardiac and vascular tissues. The company was founded on January 19, 1984 and is headquartered in Kennesaw, GA.

Head office United States
CEO James Mackin
Employees 1,600
Founded 1984
Website artivion.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today